American Society for Reproductive Medicine (ASRM) Position on COVID Vaccine Use in Pregnant Women
Jan 27, 2021
Published in: ASRM Bulletin
“COVID-19 vaccination is recommended for women who are contemplating pregnancy or who are pregnant in order to minimize risks to themselves and their pregnancy.”This most recent update further advances the position expressed in the previous update, Number 11, dated December 16, 2020, which stated that,
“The Task Force does not recommend withholding the vaccine from patients who are planning to conceive, who are currently pregnant, or who are lactating.”This position is consistent with the Advisory Committee for Immunization Practices of the U.S. Center for Disease Control and Prevention and the American College of Obstetricians and Gynecologists.
In that same report, published last December, we emphasized that a shared decision-making model should be used by patients and physicians as they evaluate whether a specific patient should seek to be vaccinated.
Given the challenges in enrolling pregnant women in prospective clinical vaccine trials, definitive data are not currently available. However, after again carefully considering the existing data relating to the dangers of COVID-19 during pregnancy, the risks of the mRNA vaccines from Moderna or Pfizer, and our understanding of the underlying biological mechanisms involved, we stand by our recommendation that pregnant women and those seeking to become pregnant should be vaccinated.
The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at email@example.com.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org